Literature DB >> 3490269

Disposition of propofol in patients undergoing surgery. A comparison in men and women.

N H Kay, J W Sear, J Uppington, I D Cockshott, E J Douglas.   

Abstract

The disposition kinetics of propofol have been determined in 12 patients (six female) receiving propofol 2.5 mg kg-1 for induction of anaesthesia, which was maintained with 67% nitrous oxide in oxygen and 1-1.5% halothane. Peripheral blood samples were collected at selected times up to 8 h after the injection of the drug, and whole blood propofol concentrations determined by HPLC with fluorescence detection. Drug concentration-time data were analysed by the non-linear regression program ELSFIT. This showed the data to be describable by a tri-exponential equation, corresponding to a three-compartment model. There were no differences in the derived kinetic indices for the male and female patients, with the exception of a greater Vdss:V gamma ratio in the males. The terminal half-life in the male patients was 262 min (SEM 44), and in the female patients 309 min (60). Vdss was 329 litre (67) and 313 litre (69) in male and female patients, respectively. The clearance in both groups was 1.8 litre min-1. Seven out of 12 patients showed significant secondary peaks in blood propofol concentration associated with recovery from anaesthesia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490269     DOI: 10.1093/bja/58.10.1075

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  16 in total

Review 1.  Propofol: a sedative-hypnotic anesthetic agent for use in ambulatory procedures.

Authors:  D M Steinbacher
Journal:  Anesth Prog       Date:  2001

2.  Randomized comparison of outcome after propofol-nitrous oxide or enflurane-nitrous oxide anaesthesia in operations of long duration.

Authors:  K Korttila; P L Ostman; E Faure; J L Apfelbaum; M Ekdawi; M F Roizen
Journal:  Can J Anaesth       Date:  1989-11       Impact factor: 5.063

3.  Pharmacokinetics of propofol when given by intravenous infusion.

Authors:  D J Morgan; G A Campbell; D P Crankshaw
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

4.  Extended blood collection period required to define distribution and elimination kinetics of propofol.

Authors:  G A Campbell; D J Morgan; K Kumar; D P Crankshaw
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 5.  New iv induction anaesthetics.

Authors:  D H Morison
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

6.  Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.

Authors:  C A Knibbe; H J Voortman; L P Aarts; P F Kuks; R Lange; H J Langemeijer; M Danhof
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

7.  Effects of total intravenous anesthesia with propofol on immuno-endocrine changes during surgical stress.

Authors:  Tetsuhiro Sakai; David O'Flaherty; Adolf H Giesecke; Akira Kudo; Kazuyoshi Hirota; Akitomo Matsuki
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

Review 8.  Propofol in patients with cardiac disease.

Authors:  N R Searle; P Sahab
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

9.  Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients.

Authors:  C O Pirttikangas; J Perttilä; M Salo
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 10.  Propofol. An update of its use in anaesthesia and conscious sedation.

Authors:  H M Bryson; B R Fulton; D Faulds
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.